Alembic Pharmaceuticals Limited (NSE:APLLTD)
987.60
+14.20 (1.46%)
Jun 6, 2025, 3:29 PM IST
Alembic Pharmaceuticals Employees
Alembic Pharmaceuticals had 14,858 employees as of March 31, 2024. The number of employees increased by 265 or 1.82% compared to the previous year.
Employees
14,858
Change (1Y)
265
Growth (1Y)
1.82%
Revenue / Employee
4.49M INR
Profits / Employee
392.66K INR
Market Cap
194.13B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Sun Pharmaceutical Industries | 43,000 |
Divi's Laboratories | 9,741 |
Cipla | 27,764 |
Apollo Hospitals Enterprise | 83,147 |
Mankind Pharma | 19,540 |
Zydus Lifesciences | 26,921 |
Aurobindo Pharma | 26,015 |
Alkem Laboratories | 17,432 |
Alembic Pharmaceuticals News
- 5 days ago - Alembic Pharma shares dip over 2% after USFDA issues 4 observations for Panelav facility - Business Upturn
- 8 days ago - Alembic Pharmaceuticals shares in focus after USFDA nod for cancer drug Bosutinib - Business Upturn
- 15 days ago - Alembic Pharmaceuticals gets USFDA final approval for Amlodipine and Atorvastatin Tablets - Business Upturn
- 23 days ago - Alembic Pharma gets USFDA nod for Rivaroxaban tablets across four strengths; to launch 2.5 mg in Q1 FY26 - Business Upturn
- 4 weeks ago - Alembic Pharma Q4 profit falls 12%, revenue rises 17% - The Times of India
- 4 weeks ago - Alembic Pharmaceuticals shares drop 2% as Q4 net profit falls 11.9% YoY to Rs 156.89 crore - Business Upturn
- 4 weeks ago - Alembic Pharmaceuticals Q4 Results: Revenue rises 16.7% YoY to ₹1,769 crore, Net profit down 11.96% YoY - Business Upturn
- 5 weeks ago - Alembic Pharma gets USFDA final nod for Ticagrelor 90 mg, tentative approval for 60 mg - Business Upturn